Brazil

Vaccination key to economic recovery, says Brazilian minister

BRASILIA, Jan. 25 (Xinhua) -- Mass vaccination against the novel coronavirus disease (COVID-19) is key to resuming economic growth, Brazil's Economy Minister Paulo Guedes said Monday.

Commenting on tax collection in 2020, which presented a real drop of 6.91 percent, Guedes stressed immunization will lead to the normalization of economic activities.

"The safe return to work is important, and mass vaccination is decisive. It is a critical success factor for the good performance of the economy," he said.

Thousands take to streets protesting Brazil’s Bolsonaro

RIO DE JANEIRO (AP) — Thousands of Brazilians took the streets for a second day Sunday to call for the impeachment of President Jair Bolsonaro, who is under fire for his government’s handling of COVID-19, which has raged through the country and claimed more than 216,000 lives.

Horn-honking cars paraded through the streets of Rio de Janeiro, Sao Paulo and a dozen or more other cities as other protesters marched on foot, some calling, “Get out Bolsonaro!”

Covid-19: Venezuelan donated oxygen arrives in Manaus, Brazil

MANAUS (Brazil), Jan 20 (NNN-TELESUR) — Authorities confirm the arrival of five trucks with oxygen in the capital of the Brazilian Amazon, Manaus, to attend to the sanitary crisis that the territory is suffering due to the Covid-19 pandemic.

The population welcomed the trucks with Venezuelan flags amidst applause. The shipment will be able to alleviate the dramatic situation suffered by the hospital network in Manaus.

Brazil approves emergency use of Chinese Sinovac, AstraZeneca COVID-19 vaccines

SAO PAULO, Jan. 17 (Xinhua) -- Brazil's Health Regulatory Agency (Anvisa) unanimously approved on Sunday the emergency use of the CoronaVac vaccine, from the Chinese laboratory Sinovac, as well as the AstraZeneca-University of Oxford vaccine against COVID-19.

The decision will allow the Brazilian government to start its vaccination plan against COVID-19 with 6 million doses of the CoronaVac vaccine, developed by Sinovac in conjunction with the Butantan Institute of Sao Paulo.

Brazilian approval of Sputnik V vaccine delayed by missing data

BRASILIA (Reuters) - Brazil’s health regulator is seeking further data on Russia’s Sputnik V coronavirus vaccine before considering its approval for emergency use.

Documents supporting drugmaker Uniao Quimica’s application for emergency use of the vaccine have been returned to the company because they did not meet its minimum criteria, the watchdog said on Saturday.

In a statement on the Health Ministry’s website, regulator Anvisa said the request failed to provide adequate assurances on Phase III clinical trials and issues related to the manufacture of the vaccine.

Brazilian pharmaceutical company applies to regulator for permit to urgently use Sputnik V

RIO DE JANEIRO, January 16. /TASS/: Brazil’s pharmaceutical company Uniao Quimica and the Russian Direct Investment Fund (RDIF) submitted an application on Friday to the Brazilian national sanitary watchdog Anvisa for permit to urgently use the Russian Sputnik V vaccine against the coronavirus, the company said in a statement.

Brazil: Amazon city scrambles to provide oxygen to COVID-19 patients

SAO PAULO (AP) — Hospital staff and relatives of COVID-19 patients rushed to provide facilities with oxygen tanks just flown into the Amazon rainforest’s biggest city as doctors chose which patients would breathe amid dwindling stocks and an effort to airlift some of them to other states.

Brazilian regulator requests additional information on Sputnik V vaccine

RIO DE JANEIRO, January 9. /TASS/: The Brazilian Health Regulatory Agency (Anvisa) requested additional information on Russia’s Sputnik V coronavirus vaccine. This is according to a statement on agency's website, which was published on Friday.

Earlier, the Uniao Quimica pharmaceutical company, which is a partner of the Russian Direct Investment Fund (RDIF), applied for permission to conduct the third phase of clinical trials of the vaccine in the country.

Brazilian watchdog reports serious "side incident" during Janssen-Cilag vaccine trials

RIO DE JANEIRO, January 9. /TASS/: Brazil’s national sanitary watchdog Anvisa reported a "serious side incident" during the national phase of clinical trials of the Janssen-Cilag vaccine.

According to a report the agency published on its website on Friday, the incident took place on January 2, but its details were not disclosed.

Brazil’s pandemic deaths top 200,000 amid a return to fun

SAO PAULO (AP) — The night before New Year’s Eve in Rio de Janeiro, thousands of revelers clad in their bathing suits crowded onto the iconic Ipanema beach to have some seaside drinks. It was one of many open-air parties occurring along Brazil’s vast coastline since the summer heat set in, and as the COVID-19 death toll climbed higher.

Subscribe to Brazil